Phoenix Life Sciences International
Denver, US · Nevada corporation
Founders & leadership
MH
Martin Henry TindallExecutive
Reported raises · per SEC filings
Form D private placements$879.7K disclosed across 1 of 2 rounds · 2018–2019
▶$40MofferedApr 2019 · Other Health CareRule 506(c)
▶$40MofferedApr 2019 · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Martin Henry TindallExecutive Officer, Director
- Offering amount
- $40M
- Minimum investment
- $50K
- Sales commissions
- $4M
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06c
▶$879.7KraisedApr 2019 · Other Health CareRule 506(b)
▶$879.7KraisedApr 2019 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Martin Henry TindallExecutive Officer, Director
- Offering amount
- $100M
- Amount sold
- $879.7K
- Minimum investment
- $50K
- Sales commissions
- $3M
- First sale
- Nov 2018
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Phoenix Life Sciences International raised?
- Phoenix Life Sciences International has disclosed $879.7K raised across 1 of its 2 known rounds.
- Where is Phoenix Life Sciences International headquartered?
- Phoenix Life Sciences International is headquartered in Denver, US.